1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Biomarcadores y Abordaje Personalizado del Cáncer (BioPAC)

Biomarcadores y Abordaje Personalizado del Cáncer (BioPAC)

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Urbanova M, Viol F, Ruiz-Cañas L, Koniaris E, Saksis R, Batres-Ramos S, Earl J, Kataki A, Buocikova V, Burikova M, Cihova M, Rojikova L, Makovicky P, Matuskova M, Kohl Y, Riedmayer A, Makova M, Baciak L, Gogola D, Rogoza O, Rovite V, Sainz B Jr, Smolkova B, Schrader J.

    Aurora kinase A inhibition as a synthetic lethality strategy in ARID1A-mutated gastroenteropancreatic neuroendocrine carcinoma

    CANCER LETTERS . 634: 218033-218033. Nº de citas: 2

    [doi:10.1016/j.canlet.2025.218033]

  • Rabadan R, Filip I, Balsells J, López de Maturana E, Langtry A, Alonso L, Sabroso-Lasa S, Moreno-Oya A, Gómez-Rubio P, Molina-Montes E, Márquez M, Milne R, Alfaro A, Lobato T, Estudillo L, Real FX, Malats N, Scarpa A, Lawlor R, Beghelli S, Alvarez-Gallego R, Cubillo A, Hidalgo M, Peinado P, Salas I, Rodríguez Pascual J, Carrato A, Earl J, Caminoa A, Guillén-Ponce C, Rodríguez-Garrote M, Longo-Muñoz F, Ferreiro R, Pachón V, Vaz MÁ, Muñoz M, Iglesias M, Ilzarbe L, Álvarez-Urturi C, Bessa X, Bory F, Márquez L, Poves I, Burdío F, Grande L, Gimeno J, Molero X, Guarner L, Balcells J, Salcedo M, Merino X, Michalski CW, Esposito I, Kleeff J, Kong B, Mota C, Löhr MJ, Huang J, Verbeke C, Ye W, Yu J, Loinaz C, Perea J, Rodríguez-Peralto JL, Teijo A, Peláez P, Farré A, Mora J, Martín M, Artigas V, Guarner C, Sancho FJ, Concepción M, Ramón Y Cajal T, Szafranska J, O'Rorke M, Murray L, Cantwell M, Barberà VM, Gallego J, Tardón A, Barneo L, Rodriguez-Suarez MM, Domínguez-Muñoz E, Pazos Y, Lozano A, Luaces M, Blanco-Antona F, Sayagués Manzano JM, Gutiérrez Troncoso ML, Orfao de Matos A, Muñoz-Bellvís L, Gress TM, Buchholz M, Neesse A, Greenhalf W, Costello E, Crnogorac-Jurcevic T, Kocher HM, Bhattacharya S, Abraham AT, Ennis D, Dowe T, Radon T, O'Driscoll D, Sharp L.

    Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosis

    Nature Communications . 16(1): 10769-10769. Nº de citas: 2

    [doi:10.1038/s41467-025-65811-y]

  • Soler G, Grávalos C, Rivera F, Safont MJ, Virgili AC, Valladares-Ayerbes M, Ferreiro-Monteagudo R, Ortiz-Morales MJ, Polo-Marques E, Kornusova-Bersheva I, Soustre E, Yao W, Élez E.

    Predictive factors of efficacy for FTD/TPI plus bevacizumab in refractory metastatic colorectal cancer patients: a subanalysis of the Spanish cohort from the SUNLIGHT phase III trial.

    Clinical & Translational Oncology . 27(11): 4203-4213. Nº de citas: 1

    [doi:10.1007/s12094-025-03907-z]

  • Van Laethem JL, Geboes K, Borbath I, Macarulla Mercade T, Lambert A, Cassier P, Prenen H, Mitry E, Blanc JF, Pilla L, Feliu J, Rodriguez Garrote M, Pazo-Cid RA, Gallego I, Smith KE, Nordbladh K, Jimenez DG, Ellmark P, Pico de Coaña Y, Ambarkhane SV, Beatty GL, O'Reilly EM.

    CD40 agonist mitazalimab with mFOLFIRINOX in untreated metastatic pancreatic cancer: Biomarkers associated with outcomes from OPTIMIZE-1

    Cell Reports Medicine . 6(10): 102407-102407. Nº de citas: 6

    [doi:10.1016/j.xcrm.2025.102407]

  • Palmerini E, Meazza C, Tamburini A, Márquez-Vega C, Bisogno G, Fagioli F, Ferraresi V, Milano GM, Coccoli L, Rubio-San-Simón A, Gallego O, Llinares Riestra ME, Manzitti C, Mora J, Vaz-Salgado MÁ, Luksch R, Mata C, Pierini M, Carretta E, Cesari M, Paioli A, Marrari A, Scotlandi K, Serra M, Asaftei SD, Gambarotti M, Picci P, Ferrari S, Valverde C, Ibrahim T, Broto JM.

    Is There a Role for Mifamurtide in Nonmetastatic High-Grade Osteosarcoma? Results From the Italian Sarcoma Group (ISG/OS-2) and Spanish Sarcoma Group (GEIS-33) Trials

    JOURNAL OF CLINICAL ONCOLOGY . 43(28): 3113-3122. Nº de citas: 12

    [doi:10.1200/JCO-25-00210]

  • Vaz-Salgado MA, Valverde-Morales C, Alvarez R, Asencio JM, Collado E, de Alava E, Diaz Beveridge R, Gómez-Mateo MC, Gracia Alegria I, Marquina G, Martin Broto J, Martínez-Trufero J, Narváez JA, Redondo A, Sebio A, Verges R, Viñals JM, García Del Muro X.

    Diagnosis and Therapy of Soft Tissue Sarcomas: Spanish Group for Research in Sarcomas (GEIS) Guidelines

    Cancers . 17(19): . Nº de citas: 4

    [doi:10.3390/cancers17193158]

  • Abal-Sanisidro M, Palencia-Campos A, Ruiz-Cañas L, García-Fernández J, Cañada-García L, Batres-Ramos S, López-López R, Moreno R, Martín-Pastor M, Sainz B Jr, de la Fuente M.

    Biocompatible self-illuminating sphingomyelin nanosystems for photodynamic-based cancer therapy

    JOURNAL OF CONTROLLED RELEASE . 385: 113982-113982. Nº de citas: 3

    [doi:10.1016/j.jconrel.2025.113982]

  • Avendaño-Ortiz J, Tribaldo A, Ballestero L, Gómez LA, Gracia I, Rodríguez JF, Ramírez NB, Bodoque-Villar R, Vaz-Salgado MÁ, Del Campo R, Redondo-Calvo FJ.

    Antimicrobial Activity of Natural Extracts Against Catheter-Colonizing Methicillin-Resistant Staphylococcus aureus Clinical Isolates

    Biomedicines . 13(9): . Nº de citas: 1

    [doi:10.3390/biomedicines13092150]

  • Parejo-Alonso B, Barneda D, Trabulo SMD, Courtois S, Compte-Sancerni S, Zurkovic J, Ruiz-Cañas L, Zheng Q, Tang J, Gaida MM, Schmitz U, Irun P, Penin-Peyta L, Crusz SM, Jagušt P, Espiau-Romera P, Royo-García A, Gordo-Ortiz A, Yuneva M, Lin ML, Huang S, Yang MH, Lanas A, Sainz B Jr, Thiele C, Heeschen C, Sancho P.

    PPARd Orchestrates a Prometastatic Metabolic Response to Microenvironmental Cues in Pancreatic Cancer

    CANCER RESEARCH . 85(17): 3275-3291. Nº de citas: 5

    [doi:10.1158/0008-5472.CAN-24-3475]

  • Melones-Herrero J, Aguilar-Rico F, Matesanz AI, Calés C, Sánchez-Pérez I, Quiroga AG.

    Antiproliferative activity in breast cancer cells of PtL2: A steroid-thiosemicarbazone platinum(II) complex

    JOURNAL OF INORGANIC BIOCHEMISTRY . 270: 112923-112923. Nº de citas: 4

    [doi:10.1016/j.jinorgbio.2025.112923]

  • Martelli V, Vidal J, Gibert J, Fernández-Rodríguez MC, Linares J, García-Alfonso P, Páez D, Alonso V, Gomez-España MA, Guix M, Santos C, Duran G, Élez E, Garcia-Carbonero R, Ferreiro R, Pineda E, Sastre J, Cano MT, Manzano JL, Losa F, Aranda E, Rivera F, Sibilio A, Toledo R, Tabernero J, Salazar R, Bellosillo B, Montagut C.

    Clinical validation of liquid biopsy-RECIST (LB-RECIST) in metastatic colorectal cancer (mCRC) patients: findings from the PLATFORM-B study

    ESMO Open . 10(9): 105760-105760. Nº de citas: 7

    [doi:10.1016/j.esmoop.2025.105760]

  • Panaitescu-Damian A, Gürcinar I, Stoica V, Paiella S, Hollenbach M, Regel I, Swibold D, Capurso G, Carrato A, Michl P, Arnes L.

    Addressing Pancreatic Exocrine Insufficiency and the Impact of Pancreatic Enzyme Replacement Therapy Shortages in Europe

    United European Gastroenterology Journal . 13(10): 2090-2092. Nº de citas: 2

    [doi:10.1002/ueg2.70113]

  • Cave DD, Di Domenico A, Fantuz M, Ciotola M, Mangini M, Buonaiuto S, Corrado B, Corona M, Saracino F, Andolfi G, Di Biase I, Cucciardi A, Carrer A, Sainz B Jr, Pirozzi T, Re DL, Colonna V, Minchiotti G, De Luca AC, Lonardo E.

    TGF-ß1-mediated downregulation of L1CAM in pancreatic ductal adenocarcinoma drives upregulation of collagen 17A1 and MMP2, facilitating tumor invasiveness and metastasis

    Cell Death & Disease . 16(1): 592-592. Nº de citas: 1

    [doi:10.1038/s41419-025-07859-8]

  • He J, Alhamwe BA, Sabroso S, Carrato A, Hidalgo M, Molero X, Iglesias M, Perea J, Farré A, Tardón A, Dominguez-Muñoz E, Barberà V, Muñoz-Bellvís L, Löhr M, Greenhalf W, O'Rorke M, Gress T, Crnogorac-Jurcevic T, Gayà A, Langtry A, Kleeff J, Lawlor R, Real FX, Renz H, Malats N.

    Low type-2 immune effectors modulate atopic diseases' protective role in pancreatic cancer risk

    INTERNATIONAL JOURNAL OF CANCER . 157(3): 468-479. Nº de citas: 3

    [doi:10.1002/ijc.35397]

  • Earl J, Kataki A, Canzian F, Costello E, Campa D, Greenhalf W.

    Targeting pancreatic cancer screening by identification of pathogenic variants of BRCA2/ BRCA1 in healthy individuals who have no known family history of pancreatic cancer: The arguments for and against

    SEMINARS IN CANCER BIOLOGY . 113: 1-8.

    [doi:10.1016/j.semcancer.2025.05.001]

  • López-López C, de Castro EM, Montes AF, Orozco EJ, Peraita SL, Vera R, Cerdá P, Calvo M, Paredes BG, de Mena ML, La Casta A, Gallego J, Adeva J, Cano JMC, Ruiz-Casado A, Vidal-Tocino R, García-García T, Pazo-Cid R, Garrote MR, Sastre J.

    Real-world management and outcomes of patients with hepatocellular carcinoma treated with systemic therapy in Spain: a patient cohort from the RETUD gastrointestinal registry

    Clinical & Translational Oncology . 28(2): 589-600. Nº de citas: 2

    [doi:10.1007/s12094-025-04010-z]

  • Alsina M, Villacampa G, de Andrea C, Vivancos A, Ponz-Sarvise M, Arrazubi V, Jimenez-Fonseca P, Diez M, Sanz-Garcia E, Martínez E, Guardeño R, Calvo M, Bugés C, Longo F, Navarro V, García-Galea E, Gros A, Ochoa MC, Lopez-Janeiro A, Sanchez-Gregorio S, Herrero C, Labiano I, Vila-Casadesús M, López D, Alexandru R, Muñoz S, Tabernero J, Melero I.

    A Phase II Study of Perioperative Avelumab plus Chemotherapy for Patients with Resectable Gastric Cancer or Gastroesophageal Junction Cancer - The MONEO Study

    CLINICAL CANCER RESEARCH . 31(14): 2890-2898. Nº de citas: 7

    [doi:10.1158/1078-0432.CCR-25-0369]

  • Villacampa A, Shamoon L, Valencia I, Morales C, Figueiras S, de la Cuesta F, Sánchez-Niño D, Díaz-Araya G, Sánchez-Pérez I, Lorenzo Ó, Sánchez-Ferrer CF, Peiró C.

    SARS-CoV-2 S Protein Reduces Cytoprotective Defenses and Promotes Human Endothelial Cell Senescence

    Aging and Disease . 16(3): 1626-1638. Nº de citas: 10

    [doi:10.14336/AD.2024.0405]